Matrubials Analysis: $2M Raised
What is Matrubials?
Matrubials develops milk-derived antibacterial therapeutics targeting infections, focusing on women's health issues like Bacterial Vaginosis.
Founded
2018
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
- Bacterial Vaginosis treatment, topical therapeutics, antibacterial therapeutics, anti-pathogenic molecules from milk, antimicrobial peptides from mammalian milk, AI-enabled technology for bioactive molecule identification.
How much Matrubials raised
Seed - $1.5 million
Approximately 39 months ago (around November 2021)Lead Investor: Not specified in the available sources.
Who are the founders of Matrubials
IS
Ishita Shah
CEO and co-founder
BG
Bruce German
Co-founder
CL
Carlito Lebrilla
Co-founder
DM
David Mills
Co-founder
Investors
- Y Combinator
- Globivest
- Sunstone Management
- National Institutes of Health
- Gaingels
- Pitch Elk Grove
See something that needs updating? Suggest edits to this profile.